Table 3.
Relation between liver fatty acid-binding protein expression and clinical features n (%)
| Characteristics |
Tumor size ≤ 2 cm |
P value |
Tumor size > 2 cm |
P value |
Total |
P value | |||
| L-FABP negative n = 11 | L-FABP positive n = 74 | L-FABP negative n = 5 | L-FABP positive n = 56 | L-FABP negative n = 16 | L-FABP positive n = 130 | ||||
| Age | 71.3 ± 7.6 | 63.4 ± 9.3 | 0.009b | 54.6 ± 10.8 | 64.8 ± 10.7 | 0.044a | 66.0 ± 11.5 | 64.0 ± 9.9 | 0.462 |
| Gender | 0.729 | 0.320 | 0.771 | ||||||
| Male | 7 (63.6) | 52 (70.3) | 5 (100) | 41 (73.2) | 12 (75.0) | 93 (71.5) | |||
| Female | 4 (36.4) | 22 (29.7) | 0 (0) | 15 (26.8) | 4 (25.0) | 37 (28.5) | |||
| Viral infection | |||||||||
| HBV | 3 (27.3) | 16 (21.6) | 0.465 | 2 (40.0) | 11 (19.6) | 0.286 | 5 (31.3) | 27 (20.8) | 0.253 |
| HCV | 7 (63.6) | 50 (67.6) | 0.732 | 3 (60.0) | 38 (67.9) | 0.806 | 10 (62.5) | 88 (67.7) | 0.761 |
| NonB nonC | 1 (9.1) | 8 (10.8) | 0.671 | 0 (0) | 7 (12.5) | 0.531 | 1 (6.2) | 15 (11.5) | 0.451 |
| Child-Pugh classification | 0.499 | 0.540 | 0.343 | ||||||
| A | 11 (100) | 71 (95.9) | 5 (100) | 52 (92.9) | 16 (100) | 123 (94.6) | |||
| B | 0 (0) | 3 (4.1) | 0 (0) | 4 (7.1) | 0 (0) | 7 (5.4) | |||
| C | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |||
a
P < 0.05, 54.6 ± 10.8 years vs 64.8 ± 10.7 years;
b
P < 0.01, 71.3 ± 7.6 years vs 63.4 ± 9.3 years. L-FABP: Liver fatty acid-binding protein; HBV: Hepatitis B virus; HCV: Hepatitis C virus.